// App-Quantinova.ai

2158 : Rheumatic Immune Related Adverse Events Associated with Cancer Immunotherapy: A Nationwide Multi-centre Canadian Cohort from the Canadian Research Group of Rheumatology in Immuno-oncology (CanRIO)

Researchers

Presenter

  • Daniel Ennis

Principal Investigators

  • Marie Hudson

  • Carrie Ye

  • Alexandra Saltman

  • Sabrina Hoa

  • Janet Pope

  • Megan Himmel

  • Nancy Maltez

  • Aurore Fifi-Mah

  • Annaliese Tisseverasinghe

  • Robert Rottapel

  • Karam Al Jumaily

  • Christina Ly

  • Liliana Cartagena

  • Shahin Jamal

Medical Centers

  • Dalhousie University, Halifax, Nova Scotia, Canada.

  • University of Toronto, Toronto, ON, Canada

  • Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada

  • University of Alberta, Edmonton, AB, Canada

  • University of Toronto, Mount Sinai Hospital and Princess Margaret Cancer Centre, Toronto, ON, Canada

  • University of Montreal, Montreal, QC, Canada

  • Western Univeristy, London, ON, Canada

  • University of Ottawa, Ottawa, ON, Canada

  • University of Calgary, Calgary, AB, Canada

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • University of Alberta, Edmonton, AB, Canada

  • Montreal University, Montreal, QC, Canada

  • Arthritis Research Canada, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved